Good Assays for Bad Immunogenicity

Media Coverage
SA-000701

GEN

Immunogenic assays are a necessity in the development of biotherapeutics. However, they pose daunting developmental challenges. Sebastien Boridy, PhD, Research Scientist of Immunogenicity at Charles River, discusses in GEN.

Read the full article